Molecular Approaches to Discover Marine Natural Product Anticancer Leads – An Update from a Drug Discovery Group Collaboration

References

• Abad MJ, Bermejo P (2001): Bioactive natural products from marine sources. In: Atta-ur-Rahman, ed., Studies in Natural Products Chemistry. Elsevier, Amsterdam, pp. 683-756.
   Google Scholar
• Abel U, Koch C, Speitling M, Hansske FG (2002): Modern methods to produce natural-product libraries. Curr Opin Chem Biol 6: 453–458.
   PubMed Web of Science ®Google Scholar
• Arabshahi L, Schmitz FJ (1987): Brominated tyrosine metabo-lites from an unidentified sponge. J Org Chem 52: 3584–3586.
   Web of Science ®Google Scholar
• Broggini M, Marchini SV, Galliera E, Borsotti P, Taraboletti G, Erba E, Sironi M, Jimeno J, Faircloth GT, Giavazzi R, D'Iricalci M (2003): Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (fit-1) autocrine loop in human leukemia cells MOLT-4. Leukemia 17: 52–59.
   Google Scholar
• Capon RJ (2001): Marine bioprospecting - Trawling for trea-sure and pleasure. Eur J Org Chem 633–645.
   Web of Science ®Google Scholar
• Cimino G, De Rosa S, De Stefano S (1984): Experientia 40: 339–340.
   Google Scholar
• Crews P, Slate DL, Gerwick WH, Schmitz FJ, Schatzman R, Strulovici B, Cannon P, Hunter LM (1991): In: Valeriote FA, Corbett TH, Baker LH, eds., Anticancer Drug Discovery and Development: Natural Products and New Molecular Models. Kluwer Academic Publishers, Boston, pp. 365–399.
   Google Scholar
• Evans JS, Musser EA, Mengel GD, Forsblad KR, Hunter JH (1961): Antitumor activity of 1-beta-D-arainofuranosylcy-tosine hydrochloride. Proc Soc Exp Biol Med 106: 350–353.
   PubMed Web of Science ®Google Scholar
• Faulkner DJ (2000): Marine pharmacology. Anton Leeuw Int J G 77: 135–145.
   PubMed Web of Science ®Google Scholar
• Fournel M, Sapieha P, Beaulieu N, Besterman J, MacLeod A (1999): Down-regulation of human DNA-(cytosine-5) methyltransferase induces cell cycle regulators p16(ink4A) and p21(WAF/Cip1) by distinct mechanisms. J Biol Chem 274: 24250–24256.
   PubMed Web of Science ®Google Scholar
• Freudenthal HD (ed.), Proceedings of the conference U Rhode Island, sponsored by Marine Technology Society, 1967.
   Google Scholar
• Fusetani N (2000): Introduction. In: Fusetani N, ed., Drugs from the Sea. Karger, Basel, pp. 1-5.
   Google Scholar
• Grant S, Roberts J, Poplin E, Tombes MB, Kyle B, Welch D, Carr M, Bear HD (1998): Phase lb trial of bryostatin 1 in patients with refractory malignancies. Clin Cancer Res 4: 611–618.
   PubMed Web of Science ®Google Scholar
• Gunawardana GP, Koehn FE, Lee AY, Clardy J, He HY, Faulkner DJ (1992): Pyridoacridine alkaloids from deep-water marine sponges of the family Pachastrellidae: Structure revision of dercitin and related compounds and correlation with the kuanoniamines. J Org Chem 57: 1523–1526.
   Web of Science ®Google Scholar
• Hamann MT, Scheuer PJ (1993): Kahalalide F: a bioactive dep-sipeptide from the sacoglasson mollusk Elysia rufescens and the green alga Bryopsis sp. J Am Chem Soc 115: 5825–5826.
   Web of Science ®Google Scholar
• Hendrich B, Bird A (1998): Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 18: 6538–6547.
   PubMed Web of Science ®Google Scholar
• Henkle T, Brunne RM, Muller H, Reichel F (1999): Statistical investigation into the structural complementarity of natural products and synthetic compounds. Angew Chem Int Ed 38: 643–647.
   PubMed Web of Science ®Google Scholar
• Holler U, Wright AD, Matthée GF, König GM, Draeger S, Aust H-J, Schulz B (2000): Fungi from marine sponges: Diver-sity, biological activity and secondary metabolites. Mycol Res 104: 1354–1365.
   Web of Science ®Google Scholar
• Huang Y, Tan M, Gosink M, Wang K, Sun Y (2002): Histone deacetylase 5 is not a p53 target gene, but its overexpres-sion inhibits tumor cell growth and induces apoptosis. Cancer Res 62: 2913–2922.
   PubMed Web of Science ®Google Scholar
• Jimenez C, Crews P (1991): Novel marine sponge derived amino acids 13. Additional psammaplin derivatives from Psammaplysilla purpurea. Tetrahedron 47: 2097–2102.
   Google Scholar
• Jung M, Hoffmann K, Brosch G, Loidl P (1997): Analogues of trichosatin A and trapoxin B as histone deacetylase inhibitors. Bioorg Med Chem Lett 7: 1655–1658
   Google Scholar
• Kijima M, Yoshida M, Sugita K, Horinouchi S, Beppu T (1993): Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. J Biol Chem 268: 22429–22435.
   PubMed Web of Science ®Google Scholar
• Kinder FR Jr (2002): Synthetic approaches toward the bengamide family of antitumor marine natural products. A review. Org Prep Proced Int 66: 559–583.
   Google Scholar
• Lee WW, Benitoez A, Goodman L, Baker BR (1960): Potential anticancer agents. XL. Synthesis of the I3-anomer of 9-(D-arabinofuranosyl)-adenine. JAm Chem Soc 82:2648–2649.
   Google Scholar
• Medina V, Edmonds B, Young G, James R, Appleton S, Zalewski P (1997): Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): Dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer Res 57: 3697–3707.
   PubMed Web of Science ®Google Scholar
• Milutinovic S, Knox J, Szyf M (2000): DNA methyltransferase inhibition induces the transcription of the tumor suppressor p21(WAF1/CIP1/sdil). J Biol Chem 275: 6353–6359.
   Google Scholar
• Moore KS, Wehrli S, Roder H, Rogers M, Forrest JN, McCrimmon D, Zasloff M (1993): Squalamine: An aminosterol antibiotic from the shark. Proc Natl Acad Sci USA 90: 1354–1358.
   Google Scholar
• Munro HG, Blunt JIY, Dumdei EJ, Hickford SJH, Lill RE, Li S, Battershill CN, Duckworth AR (1999): The Discovery and development of marine compounds with pharmacetuical potential. J Biotechnol 70: 15–25.
   PubMed Web of Science ®Google Scholar
• Nakajima H, Kim YB, Terano H, Yoshida M, Horinouchi S (1998): FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. Exptl Cell Res 241: 126–133.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM, Snader KM (2003): Natural products as sources of new drugs over the period 1981–2002. J Nat Prod 66: 102–1037.
   Google Scholar
• North TW, Cohen SS (1979): Aranucleosides and aranucleotides in viral chemotherapy. Pharmacol Ther 4: 81–108.
   PubMed Web of Science ®Google Scholar
• Pettit GR (1987): The Bryostatins. In: Herz W, Grisebach H, Kirby GW, Tamm C, eds., Progress in the Chemistry of Organic Natural Products. Springer-Verlag, New York, pp. 153-195.
   Google Scholar
• Piña IC, Gautschi JT, Wang G-Y-S, Sanders ML, Schmitz FJ, France D, Cornell-Kennon S, Sambucetti LC, Remiszewski SW, Perez LB, Bair KW, Crews P (2003): Psammaplins from the sponge Pseudoceratina purpurea: Inhibition of both histone deacetylase and DNA methyltransferase. J Org Chem 68: 3866–3877.
   PubMed Web of Science ®Google Scholar
• Proksch P, Edrada RA, Ebel R (2002): Drugs from the seas - Current status and microbiological implications. Appl Microbiol Biotechnol 59: 125–134.
   PubMed Web of Science ®Google Scholar
• Quifiod E, Crews P (1987): Phenolic constituents of Psammaplysilla. Tetrahedron Lett 28: 3229–3232.
   Web of Science ®Google Scholar
• Ramchandani S, MacLeod A, Pinard M, von Hofe E, Szyf M (1997): Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide. Proc Nall Acad Sci USA 94: 684–692.
   Google Scholar
• Remiszewski SW, Sambucetti LC, Atadja P, Bair KW, Bontempo J, Cesarz D, Chandramouli N, Chen R, Dean K, Diamantidis G, Green MA, Howell KL, Kashi R, Kwon P, Lassota P, Mou Y, Nemzek R, Perez LB, Sorensen E, Taplin F, Trogani N, Versace R, Walker H, Weltchek-Engler S, Wood AW, Wu A (2002): Discovery of NVP-LAQ284, a novel histone deacetylase inhibitor with in vitro and in vivo antitumor activity. Abs 224th Nall ACS MEDI-Part 2: 227.
   Google Scholar
• Remiszewski SW, Sambucetti LC, Atadja P, Bair KW, Cornell WD, Green MA, Howell KL, Jung M, Kwon P, Trogani N, Walker H (2002): Inhibitors of human histone deacetylase: Synthesis and enzyme and cellular activity of straight chain hydroxamates. J Med Chem 45: 753–757.
   PubMedGoogle Scholar
• Rodriguez AD, Akee RK, Scheuer PJ (1987): Two bromotyro-sine-cysteine derived metabolites from a sponge. Tetrahe-dron Lett 28: 4989–4992.
   Web of Science ®Google Scholar
• Rinehart KL, Holt TG, Fregeau NIL, Stroh JG, Keifer PA, Sun F, Li LH, Martin DG (1990): Ecteinascidins 729,743,745, 759A, 759B, and 770: Potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinate. J Org Chem 55: 4512–4515. APPl
   Google Scholar
• Rountree MR, Bachman KE, Herman JG, Baylin SB (2001): DNA methylation, chromatin inheritance, and cancer. Oncogene 20: 3156–3165.
   PubMed Web of Science ®Google Scholar
• Sakai R, Rinehart KL, Kishore V, Kundu B, Faircloth G, Gloer JB, Carney JR, Namikoshi M, Sun F, Hughes RG Jr, Gravalos DG, de Quesada TG, Wilson GR, Heid RM (1996): Structure-activity relationships of the didemnins. J Med Chem 39: 2819–2834.
   PubMed Web of Science ®Google Scholar
• Sambucetti L, Fischer D, Zabludoff S, Kwon P, Chamberlin H, Trogani N, Xu H, Cohen D (1999): Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects. J Biol Chem 274: 34940–34947.
   Google Scholar
• Shu Y-Z (1998): Recent natural products based drug develop-ment: A pharmaceutical industry perspective. J Nat Prod 61: 1053–1071.
   PubMed Web of Science ®Google Scholar
• For a review of these projects see: Suffness M, Cragg GM, Greyer MR, Grifo FJ, Johnson G, Mead JAR, Schepartz SA, Venditti JM, Wolpert M (1995): The nationa-cooperative-natural-products-drug-discovery-group (NCDDG) and international-cooperative-biodiversity-group (ICBG) pro-grams. Int J Pharmacogn 33(Suppl S): 5–16.
   Google Scholar
• Taunton J, Collins JL, Schreiber SL (1996): Synthesis of natural and modified trapoxins, useful reagents for exploring histone deacetylase function. J Am Chem Soc 118: 10412–10422.
   Web of Science ®Google Scholar
• Wright AE (1998): In: Natural products isolation methods in biotechnology, Vol 4. (R.J.P. Carmen, ed.), Humana Press Inc. (Totowa, NJ), pp. 365–408.
   Google Scholar
• Yamada K, Higuchi R (2001): Bioactive diterpenoids from Japanese soft corals. In: Bioactive Compounds from Natural Sources Taylor & Francis: London, 2001, pp. 639–674.
   Google Scholar
• Yoshida M, Kijima M, Akita M, Beppu T (1990): Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265: 17174–17179.
   PubMed Web of Science ®Google Scholar
• Yoshida M, Horinouchi S, Beppu T (1995): Trichostatin A and trapoxin: Novel chemical probes for the role of histone acetylation in chromatin structure and function. Bioessays 17: 423–430.
   PubMed Web of Science ®Google Scholar
• Zhu W, Lakshmanan R, Beal M, Otterson G (2001): DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors. Cancer Res 61: 1327–1333.
   PubMed Web of Science ®Google Scholar